Serum Institute of India postpones antibodies for private sale in Bangladesh; center around state campaigns Kumar Jeetendra | February 4, 2021 Bangladesh’s Beximco Pharmaceuticals Ltd said on Thursday the Serum Institute of India (SII) had delayed the first supplies of a COVID-19 vaccine for personal sale, instead prioritising government immunisation campaigns. Beximco is Bangladesh’s exclusive distributor of the Oxford University-AstraZeneca shot that SII, the world’s biggest vaccine maker, is producing in bulk for low- and medium-income …
Glenmark Pharma gets USFDA gesture for seizure treatment drug Kumar Jeetendra | February 4, 2021 Drug major Glenmark Pharma on Wednesday said it has received final approval from the US health regulator for Topiramate extended-release capsules, used to treat certain types of seizures. The approved product is a generic version of Qudexy XR Capsules of Upsher-Smith Laboratories, LLC. Glenmark Pharmaceuticals Ltd has received final approval from the United States Food …
Pfizer sees about $15 billion of every 2021 sales from COVID-19 immunization Kumar Jeetendra | February 2, 2021 Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German spouse BioNTech and raised its full-year profit forecast. The company said it expects total 2021 earnings of between $59.4 billion and $61.4 billion. The vaccine was among the first to be authorized for emergency …
CPhI & P-MEC China gives a glimpse of the success returning pharma events will deliver in 2021 Kumar Jeetendra | February 1, 2021 The recently hosted CPhI & P-MEC China 2020 – organized by Informa Markets and CCCMHPIE and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd. – attracted a remarkable 46,157 visits of professional pharma visitors, including 5,105 international attendees taking part online. The hybrid event has helped stimulate renewed growth and partnerships across the …
AstraZeneca to supply 9 million more antibody dose to European Union Kumar Jeetendra | February 1, 2021 Pharmaceutical company AstraZeneca has agreed to provide 9 million additional doses of its coronavirus vaccine into the European Union during the first quarter, the bloc’s executive arm said Sunday. The new target of 40 million doses by the end of March is still only half what the British-Swedish firm had originally aimed for before it …
Johnson and Johnson 1-dose shot forestalls COVID-19, however not exactly some others Kumar Jeetendra | January 29, 2021 Johnson & Johnson’s long-awaited vaccine seems to protect against COVID-19 with just 1 shot — not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses. J&J said Friday that in the U.S. and seven other nations, the single-shot vaccine was 66% effective overall at preventing …
Glenmark Pharma gets USFDA gesture for nervous system stimulant drug Kumar Jeetendra | January 29, 2021 Drug major Glenmark Pharma on Thursday said it has received final acceptance from the US health regulator for central nervous system stimulant medication Amphetamine Sulfate tablets. The approved product is a generic version of Evekeo tablets of Arbor Pharmaceuticals LLC. Quoting IQVIA sales statistics for the 12 month period ending November 2020, Glenmark said Evekeo …
Cipla champions its commitment to carbon neutrality with its 30 MW solar plant in Maharashtra Kumar Jeetendra | January 27, 2021 India; January 27, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced that it has set up a 30 MW solar group captive project in Tuljapur, Maharashtra. Spread across 115 acres, the solar project has been commissioned in partnership with AMP Energy India, and is one of the largest solar …
Albumedix submits Drug Master Files for its products in Japan Kumar Jeetendra | January 25, 2021 Nottingham, UK – January 25th, 2021 – Life Science Newswire – Albumedix Ltd. (‘Albumedix’), the world leader in recombinant human albumin (rHA), announced the submission of Drug Master Files (DMFs) to the Pharmaceutical and Medical Device Agency (PMDA) in Japan. Albumedix has submitted DMFs for two of their products in order to further support customers …
Strides Pharma gets USFDA gesture for conventional medication Kumar Jeetendra | January 25, 2021 New Delhi, Jan 25 (PTI) Strides Pharma Science on Monday said it has received approval from the US health regulator to market generic Ursodiol capsules, used in the treatment of Primary Biliary Cirrhosis (PBC), in the American market. The company”s product is bioequivalent and therapeutically equivalent to Allergan Sales” Actigall capsules, it added. Based on …
Japan to begin Covid immunizations with Pfizer vaccine Kumar Jeetendra | January 22, 2021 Japan’s vaccine programme chief Taro Kono said on Friday the country would begin coronavirus vaccinations with Pfizer’s vaccine, and aimed to start vaccinations as early as late February with 10,000 medical workers at 100 hospitals. Kono told reporters the next priority after medical workers was to vaccinate the elderly, those with health conditions and elderly …
Strides Pharma Science arm gets USFDA gesture for HIV treatment drug Kumar Jeetendra | January 15, 2021 Drug firm Strides Pharma Science on Friday said its step-down wholly-owned subsidiary, Strides Pharma Global, has obtained approval from the US health regulator for Emtricitabine and Tenofovir Disoproxil Fumarate pills, used to treat HIV. The approved product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Truvada tablets of Gilead Sciences. Strides Pharma …
